Phibro Animal Health Corp. (PAHC) Social Stream
PHIBRO ANIMAL HEALTH CORP (PAHC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PHIBRO ANIMAL HEALTH CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 2 | $23 | $17 | $20 | $11.25 | 77.78% |
| 2021-11-18 | 3 | $23 | $17 | $21 | $11.25 | 86.67% |
| 2022-02-11 | 3 | $23 | $17 | $21 | $11.25 | 86.67% |
| 2022-05-06 | 3 | $23 | $18 | $21.333 | $11.25 | 89.63% |
| 2022-08-13 | 3 | $23 | $18 | $21 | $11.25 | 86.67% |
| 2022-09-10 | 3 | $22 | $16 | $19.666 | $11.25 | 74.81% |
| 2022-09-17 | 3 | $21 | $16 | $18 | $11.25 | 60% |
| 2022-10-26 | 3 | $21 | $14 | $17.333 | $11.25 | 54.07% |
| 2022-11-09 | 3 | $20 | $14 | $17 | $11.25 | 51.11% |
| 2022-11-17 | 3 | $20 | $12 | $16.333 | $11.25 | 45.18% |
| 2023-02-08 | 4 | $20 | $12 | $16.75 | $11.25 | 48.89% |
| 2023-02-09 | 4 | $21 | $12 | $17.25 | $11.25 | 53.33% |
| 2023-08-28 | 4 | $21 | $12 | $17 | $11.25 | 51.11% |
| 2023-09-05 | 3 | $21 | $12 | $16.666 | $11.25 | 48.14% |
| 2023-11-09 | 3 | $21 | $12 | $16.333 | $11.25 | 45.18% |
| 2023-11-10 | 4 | $16 | $11 | $13.333 | $11.25 | 18.52% |
| 2023-12-07 | 5 | $16 | $9 | $11.8 | $11.25 | 4.89% |
| 2023-12-15 | 5 | $13 | $9 | $11.2 | $11.25 | -0.44% |
The Trend in the Analyst Price Target
PAHC's average price target has moved down $5.8 over the prior 13 months.
PAHC reports an average of 20.76% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 4 | 20 | 12 | 16.750 | 15.25 | 9.84% |
| 2023-05-04 | 4 | 21 | 12 | 17.000 | 14.31 | 18.8% |
| 2023-09-01 | 4 | 21 | 12 | 16.750 | 14.51 | 15.44% |
| 2023-09-05 | 3 | 21 | 12 | 16.666 | 13.43 | 24.1% |
| 2023-11-09 | 3 | 21 | 12 | 16.333 | 9.81 | 66.49% |
PAHC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.6 | 1 | 0 | 1 | 2 | 2 | 5 |
The Trend in the Broker Recommendations
Over the past 25 months, PAHC's average broker recommendation rating improved by 0.9.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PHIBRO ANIMAL HEALTH CORP's number of analysts covering the stock is higher than 210.75% of all US stocks.
- In terms of how PHIBRO ANIMAL HEALTH CORP fares relative to all US stocks, note that its average analyst price target is greater than 414.5% of that group.
- In the context of Pharmaceutical Products stocks, PHIBRO ANIMAL HEALTH CORP's variance in analysts' estimates is lower than -431.16% of them.
- PHIBRO ANIMAL HEALTH CORP's upside potential (average analyst target price relative to current price) is greater than 1225.54% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, SAGE, AMPH, and FGEN are the three stocks most similar to PHIBRO ANIMAL HEALTH CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PAHC a Buy, Hold or Sell? See the POWR Ratings now!